An Overview of Neurological and Psychiatric Complications During Post-COVID Period: A Narrative Review

References

• AbdelMassih AF, Kamel A, Mishriky F, et al. Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19. Cardiovasc Endocrinol Metab. 2020;9(3):110–120. doi:10.1097/XCE.0000000000000211
   PubMed Web of Science ®Google Scholar
• Viana R, Moyo S, Amoako DG, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in Southern Africa. Nature. 2022;603(7902):679–686. doi:10.1038/s41586-022-04411-y
   PubMed Web of Science ®Google Scholar
• Nyberg T, Ferguson NM, Nash SG, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399(10332):1303–1312. doi:10.1016/S0140-6736(22)00462-7
   PubMed Web of Science ®Google Scholar
• Krutikov M, Stirrup O, Nacer-Laidi H, et al. Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study. Lancet Healthy Longev. 2022;3(5):e347–e355. doi:10.1016/S2666-7568(22)00093-9
   PubMedGoogle Scholar
• Solomon T. Neurological infection with SARS-CoV-2 - the story so far. Nat Rev Neurol. 2021;17(2):65–66. doi:10.1038/s41582-020-00453-w
   PubMed Web of Science ®Google Scholar
• Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;41(10):2657–2669. doi:10.1007/s10072-020-04575-3
   PubMed Web of Science ®Google Scholar
• Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021;268(9):3059–3071. doi:10.1007/s00415-021-10406-y
   PubMed Web of Science ®Google Scholar
• Beghi E, Giussani G, Westenberg E, et al. Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions. J Neurol. 2022;269(5):2265–2274. doi:10.1007/s00415-021-10848-4
   PubMed Web of Science ®Google Scholar
• Hosey MM, Needham DM. Survivorship after COVID-19 ICU stay. Nat Rev Dis Primers. 2020;6(1):60. doi:10.1038/s41572-020-0201-1
   PubMed Web of Science ®Google Scholar
• Stefano GB. Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Med Sci Monit. 2021;27:e931447. doi:10.12659/MSM.931447
   PubMed Web of Science ®Google Scholar
• Roy D, Ghosh R, Dubey S, Dubey MJ, Benito-León J, Kanti Ray B. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2021;48(1):9–24. doi:10.1017/cjn.2020.173
   PubMed Web of Science ®Google Scholar
• Deng J, Zhou F, Hou W, et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021;1486(1):90–111. doi:10.1111/nyas.14506
   PubMed Web of Science ®Google Scholar
• Jamshidi MB, Lalbakhsh A, Talla J, et al. Artificial intelligence and COVID-19: deep learning approaches for diagnosis and treatment. IEEE Access. 2020;8:109581–109595. doi:10.1109/ACCESS.2020.3001973
   PubMed Web of Science ®Google Scholar
• Jamshidi MB, Lalbakhsh A, Talla J, et al. Emerging Technologies During the Era of COVID-19 Pandemic. Studies in Systems, Decision and Control. Springer, Cham; 2021:9–31.
   Google Scholar
• Balcom EF, Nath A, Power C. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease. Brain. 2021;144(12):3576–3588. doi:10.1093/brain/awab302
   PubMed Web of Science ®Google Scholar
• Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611–627. doi:10.1016/S2215-0366(20)30203-0
   PubMed Web of Science ®Google Scholar
• Rogers JP, David AS. A longer look at COVID-19 and neuropsychiatric outcomes. Lancet Psychiatry. 2021;8(5):351–352. doi:10.1016/S2215-0366(21)00120-6
   PubMed Web of Science ®Google Scholar
• Tan YK, Goh C, Leow AST, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020;50:587–595. doi:10.1007/s11239-020-02228-y
   PubMed Web of Science ®Google Scholar
• Keddie S, Pakpoor J, Mousele C, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. 2020;144:682–693. doi:10.1093/brain/awaa433
   Web of Science ®Google Scholar
• Liguori S, Moretti A, Paoletta M, Gimigliano F, Iolascon G. Rehabilitation of neuromuscular diseases during COVID-19: pitfalls and opportunities. Front Neurol. 2021;12:626319. doi:10.3389/fneur.2021.626319
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol. 2021;72(11):384–396. doi:10.33588/rn.7211.2021230
   PubMed Web of Science ®Google Scholar
• Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–427. doi:10.1016/S2215-0366(21)00084-5
   PubMed Web of Science ®Google Scholar
• Pun BT, Badenes R, Heras La Calle G, et al; COVID-19 Intensive Care International Study Group. Prevalence and risk factors for delirium in critically ill patients with COVID-19: a multicentre cohort study. Lancet Respir Med. 2021;9(3):239–250. doi:10.1016/S2213-2600(20)30552-X
   PubMed Web of Science ®Google Scholar
• Liotta EM, Batra A, Clark JR, et al. Frequent neurological manifestations and encephalopathy-associated morbidity in COVID-19 patients. Ann Clin Transl Neurol. 2020;7(11):2221–2230. doi:10.1002/acn3.51210
   PubMed Web of Science ®Google Scholar
• Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268–2270. doi:10.1056/NEJMc2008597
   PubMed Web of Science ®Google Scholar
• Garcez FB, Aliberti MJR, Poco PCE, et al. Delirium and adverse outcomes in hospitalized patients with COVID-19. J Am Geriatr Soc. 2020;68(11):2440–2446. doi:10.1111/jgs.16803
   PubMed Web of Science ®Google Scholar
• Abdo WF, Broerse CI, Grady BP, et al. Prolonged unconsciousness following severe COVID-19. Neurology. 2021;96(10):e1437–e1442. doi:10.1212/WNL.0000000000011355
   PubMed Web of Science ®Google Scholar
• Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–58. doi:10.1016/j.ijid.2020.03.062
   PubMed Web of Science ®Google Scholar
• Zanin L, Saraceno G, Panciani PP, et al. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. 2020;162(7):1491–1494. doi:10.1007/s00701-020-04374-x
   PubMed Web of Science ®Google Scholar
• Song E, Zhang C, Israelow B, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218(3):e20202135. doi:10.1084/jem.20202135
   PubMed Web of Science ®Google Scholar
• Mesci P, Macia P, Saleh A, et al. Sofosbuvir protects human brain organoids against SARS-CoV-2. bioRxiv. 2020. doi:10.1101/2020.05.30.125856
   Google Scholar
• Matschke J, Lütgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919–929. doi:10.1016/S1474-4422(20)30308-2
   PubMed Web of Science ®Google Scholar
• Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endothelitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi:10.1016/S0140-6736(20)30937-5
   PubMed Web of Science ®Google Scholar
• Thakur KT, Miller EH, Glendinning MD, et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;144(9):2696–2708. doi:10.1093/brain/awab148
   PubMed Web of Science ®Google Scholar
• Varatharaj A, Thomas N, Ellul MA, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875–882. doi:10.1016/S2215-0366(20)30287-X
   PubMed Web of Science ®Google Scholar
• Paterson RW, Brown RL, Benjamin L, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104–3120. doi:10.1093/brain/awaa240
   PubMed Web of Science ®Google Scholar
• Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767–783. doi:10.1016/S1474-4422(20)30221-0
   PubMed Web of Science ®Google Scholar
• Muccioli L, Pensato U, Cani I, Guarino M, Cortelli P, Bisulli F. COVID-19-associated encephalopathy and cytokine-mediated neuroinflammation. Ann Neurol. 2020;88(4):860–861. doi:10.1002/ana.25855
   PubMed Web of Science ®Google Scholar
• Pilotto A, Padovani A; ENCOVID-BIO Network. Reply to the letter “COVID-19-associated encephalopathy and cytokine-mediated neuroinflammation”. Ann Neurol. 2020;88(4):861–862. doi:10.1002/ana.25856
   PubMed Web of Science ®Google Scholar
• Fotuhi M, Mian A, Meysami S, Raji CA. Neurobiology of COVID-19. J Alzheimers Dis. 2020;76(1):3–19. doi:10.3233/JAD-200581
   PubMed Web of Science ®Google Scholar
• Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020;18(7):1559–1561. doi:10.1111/jth.14849
   PubMed Web of Science ®Google Scholar
• Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1–13. doi:10.1016/j.trsl.2020.04.007
   PubMed Web of Science ®Google Scholar
• Al-Dalahmah O, Thakur KT, Nordvig AS, et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol Commun. 2020;8(1):147. doi:10.1186/s40478-020-01024-2
   PubMed Web of Science ®Google Scholar
• Solomon IH, Normandin E, Bhattacharyya S, et al. Neuropathological features of COVID-19. N Engl J Med. 2020;383(10):989–992. doi:10.1056/NEJMc2019373
   PubMed Web of Science ®Google Scholar
• Kandemirli SG, Dogan L, Sarikaya ZT, et al. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. 2020;297(1):E232–E235.
   PubMed Web of Science ®Google Scholar
• Radmanesh A, Derman A, Lui YW, et al. COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology. 2020;297(1):E223–E227. doi:10.1148/radiol.2020202040
   PubMed Web of Science ®Google Scholar
• Lei Y, Zhang J, Schiavon CR, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE2. Circ Res. 2021;128(9):1323–1326. doi:10.1161/CIRCRESAHA.121.318902
   PubMed Web of Science ®Google Scholar
• Cooper SL, Boyle E, Jefferson SR, et al. Role of the renin-angiotensin-aldosterone and kinin-kallikrein systems in the cardiovascular complications of COVID-19 and long COVID. Int J Mol Sci. 2021;22(15):8255. doi:10.3390/ijms22158255
   PubMed Web of Science ®Google Scholar
• Bernard I, Limonta D, Mahal LK, Hobman TC. Endothelium infection and dysregulation by SARS-CoV-2: evidence and caveats in COVID-19. Viruses. 2020;13(1):29. doi:10.3390/v13010029
   PubMed Web of Science ®Google Scholar
• Al Saiegh F, Ghosh R, Leibold A, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry. 2020;91(8):846–848. doi:10.1136/jnnp-2020-323522
   PubMed Web of Science ®Google Scholar
• Bryce C, Grimes Z, Pujadas E, et al. Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience. medRxiv. 2020. doi:10.1101/2020.05.18.20099960
   Google Scholar
• Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45. doi:10.1186/s40249-020-00662-x
   PubMed Web of Science ®Google Scholar
• Kandemirli SG, Altundag A, Yildirim D, Tekcan Sanli DE, Saatci O. Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia. Acad Radiol. 2021;28(1):28–35. doi:10.1016/j.acra.2020.10.006
   PubMed Web of Science ®Google Scholar
• Llorens S, Nava E, Muñoz-López M, Sánchez-Larsen Á, Segura T. neurological Symptoms of COVID-19: the Zonulin Hypothesis. Front Immunol. 2021;12:665300. doi:10.3389/fimmu.2021.665300
   PubMed Web of Science ®Google Scholar
• Santiesteban-Lores LE, Amamura TA, da Silva TF, et al. A double edged-sword - the complement system during SARS-CoV-2 infection. Life Sci. 2021;272:119245.
   PubMed Web of Science ®Google Scholar
• Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75. doi:10.1016/j.cytogfr.2020.06.001
   PubMed Web of Science ®Google Scholar
• Villapol S. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome. Transl Res. 2020;226:57–69. doi:10.1016/j.trsl.2020.08.004
   PubMed Web of Science ®Google Scholar
• Alquisiras-Burgos I, Peralta-Arrieta I, Alonso-Palomares LA, Zacapala-Gómez AE, Salmerón-Bárcenas EG, Aguilera P. Neurological complications associated with the blood-brain barrier damage induced by the inflammatory response during SARS-CoV-2 infection. Mol Neurobiol. 2020;58:520–535. doi:10.1007/s12035-020-02134-7
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang M, Jr GG, et al. ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response. Cell Stem Cell. 2021;28(2):331–342.e5. doi:10.1016/j.stem.2020.12.018
   PubMed Web of Science ®Google Scholar
• Hu J, Jolkkonen J, Zhao C. Neurotropism of SARS-CoV-2 and its neuropathological alterations: similarities with other coronaviruses. Neurosci Biobehav Rev. 2020;119:184–193. doi:10.1016/j.neubiorev.2020.10.012
   PubMed Web of Science ®Google Scholar
• Placantonakis DG, Aguero-Rosenfeld M, Flaifel A, et al. SARS-CoV-2 is not detected in the cerebrospinal fluid of encephalopathic COVID-19 patients. Front Neurol. 2020;11:587384. doi:10.3389/fneur.2020.587384
   PubMed Web of Science ®Google Scholar
• Kumar M, Thakur AK. Neurological manifestations and comorbidity associated with COVID-19: an overview. Neurol Sci. 2020;41(12):3409–3418. doi:10.1007/s10072-020-04823-6
   PubMed Web of Science ®Google Scholar
• Mao L, Jin H, Wang M, et al. Neurological manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi:10.1001/jamaneurol.2020.1127
   PubMed Web of Science ®Google Scholar
• Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. doi:10.1001/jama.2020.12603
   PubMed Web of Science ®Google Scholar
• Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurological manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060–e1070. doi:10.1212/WNL.0000000000009937
   PubMed Web of Science ®Google Scholar
• Jarrahi A, Ahluwalia M, Khodadadi H, et al. Neurological consequences of COVID-19: what have we learned and where do we go from here? J Neuroinflammation. 2020;17(1):286. doi:10.1186/s12974-020-01957-4
   PubMed Web of Science ®Google Scholar
• Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251–2261. doi:10.1007/s00405-020-05965-1
   PubMed Web of Science ®Google Scholar
• Saniasiaya J, Islam MA, Abdullah B. Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID-19): a meta-analysis of 27492 patients. Laryngoscope. 2021;131(4):865–878. doi:10.1002/lary.29286
   PubMed Web of Science ®Google Scholar
• Bilinska K, Jakubowska P, Von Bartheld CS, Butowt R. Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age. ACS Chem Neurosci. 2020;11(11):1555–1562. doi:10.1021/acschemneuro.0c00210
   PubMed Web of Science ®Google Scholar
• Eliezer M, Hamel AL, Houdart E, et al. Loss of smell in patients with COVID-19: MRI data reveal a transient edema of the olfactory clefts. Neurology. 2020;95(23):e3145–e3152. doi:10.1212/WNL.0000000000010806
   PubMed Web of Science ®Google Scholar
• Paderno A, Mattavelli D, Rampinelli V, et al. Olfactory and gustatory outcomes in COVID-19: a prospective evaluation in non-hospitalized subjects. Otolaryngol Head Neck Surg. 2020;163(6):1144–1149. doi:10.1177/0194599820939538
   PubMed Web of Science ®Google Scholar
• Beyrouti R, Adams ME, Benjamin L, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91(8):889–891. doi:10.1136/jnnp-2020-323586
   PubMed Web of Science ®Google Scholar
• Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268(4):1133–1170. doi:10.1007/s00415-020-10124-x
   PubMed Web of Science ®Google Scholar
• Khera D, Didel S, Panda S, Tiwari S, Singh K. Concurrent longitudinally extensive transverse myelitis and Guillain-Barré syndrome in a child secondary to COVID-19 infection: a severe neuroimmunologic complication of COVID-19. Pediatr Infect Dis J. 2021;40(6):e236–e239. doi:10.1097/INF.0000000000003124
   PubMed Web of Science ®Google Scholar
• Guilmot A, Maldonado Slootjes S, Sellimi A, et al. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2020;268(3):751–757. doi:10.1007/s00415-020-10108-x
   PubMed Web of Science ®Google Scholar
• Sluis WM, Linschoten M, Buijs JE, et al. Risk, clinical course, and outcome of ischemic stroke in patients hospitalized with COVID-19: a Multicenter Cohort Study. Stroke. 2021;52(12):3978–3986. doi:10.1161/STROKEAHA.121.034787
   PubMed Web of Science ®Google Scholar
• Suzuki K, Numao A, Komagamine T, et al. Impact of the COVID-19 pandemic on the quality of life of patients with parkinson’s disease and their caregivers: a single-center survey in Tochigi prefecture. J Parkinsons Dis. 2021;11(3):1047–1056. doi:10.3233/JPD-212560
   PubMedGoogle Scholar
• Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099. doi:10.1111/jth.14817
   PubMed Web of Science ®Google Scholar
• Gupta N, Zhao YY, Evans CE. The stimulation of thrombosis by hypoxia. Thromb Res. 2019;181:77–83. doi:10.1016/j.thromres.2019.07.013
   PubMed Web of Science ®Google Scholar
• Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9–14. doi:10.1016/j.thromres.2020.04.024
   PubMed Web of Science ®Google Scholar
• Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. doi:10.1007/s00134-020-06062-x
   PubMed Web of Science ®Google Scholar
• Siniscalchi A, Could GL. COVID-19 represent a negative prognostic factor in patients with stroke? Infect Control Hosp Epidemiol. 2020;41(9):1115–1116. doi:10.1017/ice.2020.146
   PubMed Web of Science ®Google Scholar
• Siniscalchi A, Gallelli L, Malferrari G, et al. Cerebral stroke injury: the role of cytokines and brain inflammation. J Basic Clin Physiol Pharmacol. 2014;25(2):131–137. doi:10.1515/jbcpp-2013-0121
   PubMedGoogle Scholar
• Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6–e12. doi:10.1016/j.jinf.2020.04.002
   Web of Science ®Google Scholar
• Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province. China. JAMA Ophthalmol. 2020;138(5):575–578. doi:10.1001/jamaophthalmol.2020.1291
   PubMed Web of Science ®Google Scholar
• Vaibhav K, Braun M, Alverson K, et al. Neutrophil extracellular traps exacerbate neurological deficits after traumatic brain injury. Sci Adv. 2020;6:eaax8847. doi:10.1126/sciadv.aax8847
   PubMed Web of Science ®Google Scholar
• Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28(7):1195–1199. doi:10.1002/oby.22831
   PubMed Web of Science ®Google Scholar
• Nakeshbandi M, Maini R, Daniel P, et al. The impact of obesity on COVID-19 complications: a retrospective cohort study. Int J Obes. 2020;44(9):1832–1837. doi:10.1038/s41366-020-0648-x
   Web of Science ®Google Scholar
• Malik VS, Ravindra K, Attri SV, Bhadada SK, Singh M. Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis. Environ Sci Pollut Res Int. 2020;27(33):42115–42123. doi:10.1007/s11356-020-10132-4
   PubMed Web of Science ®Google Scholar
• Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8(9):782–792. doi:10.1016/S2213-8587(20)30238-2
   PubMed Web of Science ®Google Scholar
• Delly F, Syed MJ, Lisak RP, Zutshi D. Myasthenic crisis in COVID-19. J Neurol Sci. 2020;414:116888. doi:10.1016/j.jns.2020.116888
   PubMed Web of Science ®Google Scholar
• Barzegar M, Mirmosayyeb O, Nehzat N, et al. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e753. doi:10.1212/NXI.0000000000000753
   PubMed Web of Science ®Google Scholar
• de Figueiredo CS, Sandre PC, Portugal LCL, et al. COVID-19 pandemic impact on children and adolescents’ mental health: biological, environmental, and social factors. Prog Neuropsychopharmacol Biol Psychiatry. 2022;106:110171. doi:10.1016/j.pnpbp.2020.110171
   Web of Science ®Google Scholar
• Grolli RE, Mingoti MED, Bertollo AG, et al. Impact of COVID-19 in the mental health in elderly: psychological and biological updates. Mol Neurobiol. 2021;58(5):1905–1916. doi:10.1007/s12035-020-02249-x
   PubMed Web of Science ®Google Scholar
• Aamir A, Awan S, de Filippis R, Diwan MN, Ullah I. Effect of COVID-19 on mental health rehabilitation centers. J Psychosoc Rehabil Ment Health. 2020;21:1–4.
   Google Scholar
• Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi:10.1016/j.eclinm.2021.101019
   PubMedGoogle Scholar
• Ziauddeen N, Gurdasani D, O’Hara ME, et al. Characteristics of Long COVID: findings from a social media survey. medRxiv. 2021. doi:10.1101/2021.03.21.21253968
   Google Scholar
• Ayoubkhani D, Khunti K, Nafilyan V, et al. Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. medRxiv. 2021. doi:10.1101/2021.01.15.21249885
   Google Scholar
• Zhao YM, Shang YM, Song WB, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi:10.1016/j.eclinm.2020.100463
   PubMedGoogle Scholar
• Zhang T, Huang WS, Guan W, et al. Risk factors and predictors associated with the severity of COVID-19 in China: a systematic review, meta-analysis, and meta-regression. J Thorac Dis. 2020;12(12):7429–7441. doi:10.21037/jtd-20-1743
   PubMed Web of Science ®Google Scholar
• Pellinen J, Carroll E, Friedman D, et al. Continuous EEG findings in patients with COVID-19 infection admitted to a New York academic hospital system. Epilepsia. 2020;61(10):2097–2105. doi:10.1111/epi.16667
   PubMed Web of Science ®Google Scholar
• Kremer S, Lersy F, de Sèze J, et al. Brain MRI findings in severe COVID-19: a Retrospective Observational Study. Radiology. 2020;297(2):E242–E251. doi:10.1148/radiol.2020202222
   PubMed Web of Science ®Google Scholar
• Abdel-Mannan O, Eyre M, Löbel U, et al. Neurological and radiographic findings associated with COVID-19 infection in children. JAMA Neurol. 2020;77(11):1440–1445. doi:10.1001/jamaneurol.2020.2687
   PubMed Web of Science ®Google Scholar
• Marshall M. The lasting misery of coronavirus long-haulers. Nature. 2020;585(7825):339–341. doi:10.1038/d41586-020-02598-6
   PubMed Web of Science ®Google Scholar
• Berlit P, Bösel J, Gahn G, Isenmann S, Meuth SG, Nolte CH. “Neurological manifestations of COVID-19”-guideline of the German society of neurology. Neurol Res Pract. 2020;2:51. doi:10.1148/radiol.2020201697
   PubMedGoogle Scholar
• Association of British Neurologists Guidance on COVID-19 for people with neurological conditions, their doctors and carers; 2020. Available from: https://cdn.ymaws.com/www.theabn.org/resource/collection/C5F38B64-DC8F-4C67-B6FCF22B2CDB0EE5/ABN_Neurology_COVID-19_Guidance_v6_9.4.20_FP.pdf. Accessed July 20, 2022.
   Google Scholar
• Ayres JS. Surviving COVID-19: a disease tolerance perspective. Sci Adv. 2020;6(18):eabc1518. doi:10.1126/sciadv.abc1518
   PubMed Web of Science ®Google Scholar
• McCarville JL, Ayres JS. Disease tolerance: concept and mechanisms. Curr Opin Immunol. 2018;50:88–93. doi:10.1016/j.coi.2017.12.003
   PubMed Web of Science ®Google Scholar
• Zaki MM, Lesha E, Said K, et al. Cell therapy strategies for COVID-19: current approaches and potential applications. Sci Adv. 2021;33:eabg5995. doi:10.1126/sciadv.abg5995
   Web of Science ®Google Scholar
• Jamshidi E, Babajani A, Soltani P, Niknejad H. Proposed mechanisms of targeting COVID-19 by delivering mesenchymal stem cells and their exosomes to damaged organs. Stem Cell Rev Rep. 2021;17(1):176–192. doi:10.1007/s12015-020-10109-3
   PubMed Web of Science ®Google Scholar
• Spitalieri P, Centofanti F, Murdocca M, et al. Two different therapeutic approaches for SARS-CoV-2 in hiPSCs-derived lung organoids. Cells. 2022;11(7):1235. doi:10.3390/cells11071235
   PubMed Web of Science ®Google Scholar
• Toor SM, Saleh R, Sasidharan Nair V, Taha RZ, Elkord E. T-cell responses and therapies against SARS-CoV-2 infection. Immunology. 2021;162(1):30–43. doi:10.1111/imm.13262
   PubMed Web of Science ®Google Scholar
• Chen D, Huang Y, Shi Z, et al. Demyelinating processes in aging and stroke in the central nervous system and the prospect of treatment strategy. CNS Neurosci Ther. 2020;26(12):1219–1229. doi:10.1111/cns.13497
   PubMed Web of Science ®Google Scholar